Skip to main content
39°
Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Business Service Directory
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biodesix, Inc. - Common Stock
(NQ:
BDSX
)
0.6277
+0.0216 (+3.56%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 2, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biodesix, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024
April 24, 2024
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual Meeting
April 09, 2024
From
Biodesix, Inc.
Via
Business Wire
S&P 500 Gains Over 1%; GCT Semiconductor Shares Spike Higher
April 05, 2024
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Friday. The Dow traded up 0.89% to 38,941.18 while the NASDAQ rose 1.26% to 16,251.98. The...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Biodesix Reports 65% Growth In Lung Diagnostic Test Volume In Q4
March 02, 2024
Biodesix Inc. reported strong Q4 performance, with significant revenue growth.
Via
Talk Markets
Biodesix: Q4 Earnings Insights
March 01, 2024
Via
Benzinga
Biodesix's Earnings Outlook
February 29, 2024
Via
Benzinga
Why Byrna Technologies Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
April 05, 2024
Shares of Byrna Technologies Inc. (NASDAQ: BYRN) rose sharply during Friday’s session after the company reported better-than-expected first-quarter revenue, and announced a CFO transition.
Via
Benzinga
Gold Surges Over 1%; Biodesix Shares Plummet
April 05, 2024
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 200 points on Friday. The Dow traded up 1.01% to 38,987.23 while the NASDAQ rose 1.50% to 16,289.37. The...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Dow Jumps Over 100 Points; US Economy Adds 303,000 Jobs In March
April 05, 2024
U.S. stocks traded higher this morning, with the Dow Jones gaining more than 100 points on Friday. Following the market opening Friday, the Dow traded up 0.30% to 38,713.29 while the NASDAQ rose 0.35%...
Via
Benzinga
Topics
Economy
Stocks
Exposures
Economy
US Equities
Recap: Biodesix Q3 Earnings
November 07, 2023
Via
Benzinga
Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement
April 05, 2024
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center
March 25, 2024
From
Biodesix, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
March 01, 2024
Via
Benzinga
Earnings Scheduled For March 1, 2024
March 01, 2024
Companies Reporting Before The Bell • McEwen Mining (NYSE:MUX) is estimated to report quarterly loss at $0.28 per share on revenue of $71.72 million.
Via
Benzinga
Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business Highlights
March 01, 2024
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Participate in the TD Cowen 44th Annual Health Care Conference
February 26, 2024
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Report Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024
February 16, 2024
From
Biodesix, Inc.
Via
Business Wire
3 Penny Stocks to Turn $999 Into $1 Million: January 2024
January 26, 2024
With our strengthening economy, you need to invest in penny stocks that will deliver high future returns, these three are your best bets.
Via
InvestorPlace
Topics
Economy
Exposures
Economy
Biodesix Enhances Access to Nodify Lung® Testing with Launch of New Blood Draw Method
November 14, 2023
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Participate in Two Upcoming Investor Conferences in November
November 09, 2023
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces Third Quarter 2023 Results and Highlights
November 07, 2023
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Report Third Quarter 2023 Financial Results on November 7, 2023
October 24, 2023
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Present New Data on Nodify Lung® Testing at CHEST 2023 Annual Meeting
October 03, 2023
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces Two Presentations on Lung Cancer Treatment Guidance Tests at the IASLC 2023 World Lung Conference on Lung Cancer
September 07, 2023
From
Biodesix, Inc.
Via
Business Wire
Biodesix to Participate in Two Upcoming Investor Conferences in September
September 05, 2023
From
Biodesix, Inc.
Via
Business Wire
Kingstone Companies And 3 Other Stocks Under $2 Insiders Are Buying
August 24, 2023
The Dow Jones closed higher by over 180 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Biodesix Announces Presentation of New Nodify XL2® Data at AABIP Conference Highlighting Increased Proportion of Biopsies Diagnosing Cancer
August 22, 2023
From
Biodesix, Inc.
Via
Business Wire
Biodesix Announces Second Quarter 2023 Results and Highlights
August 07, 2023
From
Biodesix, Inc.
Via
Business Wire
Top 5 Health Care Stocks That May Crash In Q3
August 07, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
Biodesix to Participate in the Canaccord Genuity 43rd Annual Growth Conference
August 01, 2023
From
Biodesix, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.